Tharimmune

About:

Tharimmune is a development-stage company advancing improved therapies for patients with cancer.

Website: https://www.hillstreambio.com/

Top Investors: Gravitas Capital, SDS Capital Group

Description:

Hillstream BioPharma is a development-stage company advancing improved therapies for patients with cancer via a unique QUATRAMERTM nanoparticle platform. This unique technology enables intranuclear and intracellular delivery of small molecules, peptides, genes, other macromolecules and biologics to the tumor cello, while significantly minimizing exposure to normal tissues.